Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report.

HL, Chan; A, Thompson; M, Martinot-Peignoux; T, Piratvisuth; M, Cornberg; MR, Brunetto; HL, Tillmann; JH, Kao; JD, Jia; H, Wedemeyer; S, Locarnini; HL, Janssen; P, Marcellin

doi:10.1016/j.jhep.2011.06.006

Public

Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report.

Shared by NobleBlocks on Jun 28, 2011 • 12:00 AM UTC

Authors:

Chan HL

Thompson A

Martinot-Peignoux M

Abstract

Quantitative HBsAg had been suggested to be helpful in management of HBV, but assays were cumbersome. The recent availability of commercial quantitative assays has restarted the interest in quantitative serum hepatitis B surface antigen (HBsAg) as a biomarker for prognosis and treatment response in ...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!